JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB234039

Neutral Red Assay Kit - Cell Viability / Cytotoxicity

Be the first to review this product! Submit a review

|

(9 Publications)

Neutral Red Assay Kit - Cell Viability/Cytotoxicity (ab234039) is simple, accurate and reproducible.

Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
2 Images
Functional Studies - Neutral Red Assay Kit - Cell Viability / Cytotoxicity (AB234039)
  • FuncS

Supplier Data

Functional Studies - Neutral Red Assay Kit - Cell Viability / Cytotoxicity (AB234039)

Doxorubicin dose-response curve.

Dose-response curve of MCF7 (human breast adenocarcinoma cell line) cells treated with doxorubicin for 72 hours determined using the Neutral Red Assay Kit - Cell Viability / Cytotoxicity (ab234039). Assays were performed according to the kit protocol in triplicate.

Functional Studies - Neutral Red Assay Kit - Cell Viability / Cytotoxicity (AB234039)
  • FuncS

Supplier Data

Functional Studies - Neutral Red Assay Kit - Cell Viability / Cytotoxicity (AB234039)

Doxorubicin dose-response curve.

Dose-response curve of HepG2 (human liver hepatocellular carcinoma cell line) cells treated with doxorubicin for 72 hours determined using the Neutral Red Assay Kit - Cell Viability / Cytotoxicity (ab234039). Assays were performed according to the kit protocol in triplicate.

Key facts

Detection method

Colorimetric

Sample types

Suspension cells, Adherent cells

Assay type

Cell-based

Results type

Quantitative

Assay Platform

Microplate reader

Product details

Neutral Red Assay Kit - Cell Viability/Cytotoxicity (ab234039) is simple, accurate and reproducible. This kit offers an excellent and efficient method for in vitro cytotoxicity studies as well as high-throughput drug screening that can detect between 5,000-50,000 cells per well. It includes Doxorubicin as a positive control.

Neutral red cell cytotoxicity assay is one of the common methods used to detect cell viability or drug cytotoxicity. The principle of this assay is based on the detection of viable cells via the uptake of the dye neutral red. Neutral red is a eurhodin dye that stains lysosomes in viable cells. Viable cells can take up neutral red via active transport and incorporate the dye into their lysosomes but non-viable cells cannot not take up this chromophore. Consequently, after washing, viable cells can release the incorporated dye in under acidifiedextracted conditions. The amount of released dye can be used to determine the total number of viable cells or drug cytotoxicity. The neutral red uptake assay provides a quantitative measurement of the number of viable cells and can be measured at OD 540 nm.

This product is manufactured by BioVision, an Abcam company and was previously called K447 Neutral Red Cell Cytotoxicity Assay Kit. K447-1000 is the same size as the 1000 test size of ab234039.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "1000Test": { "sellingSize": "1000 Test", "publicAssetCode":"ab234039-1000Test", "assetComponentDetails": [ { "size":"1 x 70 mL", "name":"10X Wash Buffer I", "number":"AB234039-CMP01", "productcode":"" }, { "size":"1 x 2 mL", "name":"100X Neutral Red Staining Solution", "number":"AB234039-CMP04", "productcode":"" }, { "size":"1 x 100 µL", "name":"Doxorubicin", "number":"AB234039-CMP02", "productcode":"" }, { "size":"1 x 75 mL", "name":"2X Solubilization Solution I", "number":"AB234039-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

International journal of nanomedicine 20:3653-3670 PubMed40130196

2025

Cutaneous Evaluation of FeO Nanoparticles: An Assessment Based on 2D and 3D Human Epidermis Models Under Standard and UV Conditions.

Applications

Unspecified application

Species

Unspecified reactive species

Claudia Geanina Watz,Elena-Alina Moacă,Andreea Cioca,Lenuța Maria Șuta,Lavinia Krauss Maldea,Ioana Zinuca Magyari-Pavel,Mirela Nicolov,Ioan-Ovidiu Sîrbu,Felicia Loghin,Cristina A Dehelean

Frontiers in medicine 11:1414331 PubMed39267969

2024

SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages.

Applications

Unspecified application

Species

Unspecified reactive species

Aldo Barrera,Constanza Martínez-Valdebenito,Jenniffer Angulo,Carlos Palma,Juan Hormazábal,Cecilia Vial,Ximena Aguilera,Pablo Castillo-Torres,Catalina Pardo-Roa,María Elvira Balcells,Bruno Nervi,Nicole Le Corre,Marcela Ferrés

Journal of vascular research 60:213-226 PubMed37778342

2023

Protease-Activated Receptor 2 Controls Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Mitogen-Activated Protein Kinase Kinase 1/2-Dependent Manner.

Applications

Unspecified application

Species

Unspecified reactive species

Madison D Williams,Michael T Bullock,Sean C Johnson,Nathan A Holland,Danielle M Vuncannon,Joani Zary Oswald,Shaquria P Adderley,David A Tulis

PeerJ 11:e14981 PubMed36968001

2023

Development of a new generation of miniemulsion based on cottonseed oil with α-tocopherol and ZnO and evaluation of its adjuvant activity.

Applications

Unspecified application

Species

Unspecified reactive species

Gustavo Sobrevilla-Hernández,Moisés Armides Franco-Molina,Diana G Zárate-Triviño,Jorge R Kawas,Sara Paola Hernández-Martínez,Paola Leonor García-Coronado,Silvia Elena Santana-Krímskaya,Cynthia Aracely Alvizo-Báez,Cristina Rodríguez-Padilla

Life (Basel, Switzerland) 13: PubMed36836952

2023

Helixor-M Suppresses Immunostimulatory Activity through TLR4-Dependent NF-κB Pathway in RAW 264.7 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Doil Park,Hyun Min Ko,Wona Jee,So Mi Park,Ye Rin Park,Ji Hoon Jung,Hyung Suk Kim,Won Seok Chung,Sang Ki Kim,Jong Sup Chung,Hyeung Jin Jang

Frontiers in pharmacology 13:861311 PubMed35571112

2022

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Malgorzata Cyranka,Thomas Monfeuga,Natascia Vedovato,Chelsea M Larabee,Anandhakumar Chandran,Enrique M Toledo,Heidi de Wet

Pathogens (Basel, Switzerland) 11: PubMed35215179

2022

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives.

Applications

Unspecified application

Species

Unspecified reactive species

Renee W Y Chan,Kin P Tao,Jiqing Ye,Kevin K Y Lui,Xiao Yang,Cong Ma,Paul K S Chan

Science advances 7: PubMed34193418

2021

Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.

Applications

Unspecified application

Species

Unspecified reactive species

Namshik Han,Woochang Hwang,Konstantinos Tzelepis,Patrick Schmerer,Eliza Yankova,Méabh MacMahon,Winnie Lei,Nicholas M Katritsis,Anika Liu,Ulrike Felgenhauer,Alison Schuldt,Rebecca Harris,Kathryn Chapman,Frank McCaughan,Friedemann Weber,Tony Kouzarides

Molecules (Basel, Switzerland) 25: PubMed32178275

2020

Chemical Characteristics and Anticancer Activity of Essential Oil from L. Rhizomes and Roots.

Applications

Unspecified application

Species

Unspecified reactive species

Piotr Sugier,Joanna Jakubowicz-Gil,Danuta Sugier,Radosław Kowalski,Urszula Gawlik-Dziki,Barbara Kołodziej,Dariusz Dziki
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com